NFKB1 and nasopharyngeal carcinoma: TRAF3, a key negative regulator of the non-canonical NF-κB pathway in NPC, was found to be mutated in 8.6% cases (9/105 cases), a rate higher than previously reported in NPC (1/33 cases; 3.0%) (refs 13, 14).